FDA meeting to pick next winter's flu shot is canceled, in ominous sign for US vaccine policy

A key FDA advisory panel meeting for selecting next winter's flu vaccine strains has been unexpectedly canceled, raising concerns about US vaccine policy effectiveness and decision-making processes. The cancellation's implications could impact vaccine preparation timelines and public health readiness for the upcoming flu season.